Simethicone Pediatric Dosing
For infants under 2 years, simethicone drops are dosed at 20 mg (0.3 mL) orally after each feeding, up to 12 times daily (maximum 240 mg/day), while children 2-12 years receive 40 mg orally after meals and at bedtime as needed, not exceeding 480 mg/day.
Age-Specific Dosing
Infants Under 2 Years
- Dose: 20 mg (0.3 mL of drops) orally
- Frequency: After each feeding
- Maximum: Up to 12 times per day (240 mg total daily dose)
- Standard concentration is typically 40 mg/0.6 mL, so 0.3 mL delivers 20 mg
Children 2-12 Years
- Dose: 40 mg orally
- Frequency: After meals and at bedtime as needed
- Maximum: 480 mg per day
Children ≥12 Years and Adults
- Dose: 40-125 mg orally 1
- Frequency: After meals and at bedtime as needed
- Maximum: 500 mg per day
Clinical Context and Evidence
The evidence base for simethicone in pediatrics is mixed and limited. While an open-label trial showed 86% improvement in infant colic symptoms after 7 days 2, a subsequent randomized controlled trial demonstrated no superiority over placebo for colic treatment 3. Simethicone was no more effective than placebo despite both producing perceived symptom improvements.
However, simethicone does show efficacy in specific clinical scenarios:
- Postoperative abdominal discomfort: Infants receiving simethicone achieved comfort earlier and required fewer rescue medications compared to placebo 4
- Endoscopic preparation: Recent pediatric meta-analysis showed improved visualization clarity and reduced procedure time without increased adverse events 5
Important Caveats
Drug Interactions
Avoid concurrent use with oral lactase in infants being treated for lactose intolerance. A 2024 study found that simethicone significantly reduced lactase treatment efficacy, suggesting a clinically relevant drug interaction 6. This is particularly important since both medications are commonly used in infants with gastrointestinal symptoms.
Safety Profile
Simethicone is generally well-tolerated with minimal systemic absorption. No significant differences in adverse events (nausea, vomiting, abdominal distension, or pain) have been documented in pediatric studies 5.
Realistic Expectations
Given the placebo-controlled evidence, set appropriate expectations with families that simethicone may not provide benefit beyond placebo for common infant colic, though it remains safe to trial. The medication works by reducing surface tension of gas bubbles, theoretically facilitating their elimination, but clinical benefit for functional symptoms remains unproven.